Cosmos Holdings Achieves Positive Adjusted Net Income and Positive Adjusted EBITDA for the Third Qua

CHICAGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today provided a business update and reported financial results for the third quarter ended September 30, 2021.